FACCHINI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 10.297
AS - Asia 8.864
EU - Europa 7.788
SA - Sud America 533
AF - Africa 516
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 28.025
Nazione #
US - Stati Uniti d'America 10.201
CN - Cina 2.500
GB - Regno Unito 2.342
VN - Vietnam 2.297
SG - Singapore 2.288
DE - Germania 1.196
UA - Ucraina 926
IT - Italia 737
SE - Svezia 704
FR - Francia 570
HK - Hong Kong 497
IN - India 485
RU - Federazione Russa 481
BR - Brasile 400
IE - Irlanda 257
JP - Giappone 203
ZA - Sudafrica 168
EE - Estonia 167
KR - Corea 147
TG - Togo 115
SC - Seychelles 107
BD - Bangladesh 88
FI - Finlandia 67
AR - Argentina 66
CH - Svizzera 61
JO - Giordania 54
NL - Olanda 53
CA - Canada 49
BG - Bulgaria 47
CI - Costa d'Avorio 47
NG - Nigeria 39
PH - Filippine 38
GR - Grecia 37
BE - Belgio 34
ID - Indonesia 34
AT - Austria 33
TR - Turchia 31
IQ - Iraq 30
TH - Thailandia 30
EC - Ecuador 29
MX - Messico 27
AU - Australia 22
PK - Pakistan 19
LB - Libano 18
SA - Arabia Saudita 18
TW - Taiwan 18
PL - Polonia 15
MY - Malesia 14
UZ - Uzbekistan 14
CL - Cile 11
RO - Romania 11
ES - Italia 10
CO - Colombia 9
CZ - Repubblica Ceca 9
KE - Kenya 8
TN - Tunisia 8
VE - Venezuela 8
LT - Lituania 7
EG - Egitto 6
IL - Israele 6
IR - Iran 6
MA - Marocco 6
PY - Paraguay 6
AZ - Azerbaigian 5
HR - Croazia 5
CR - Costa Rica 4
DZ - Algeria 4
HN - Honduras 4
MD - Moldavia 4
AE - Emirati Arabi Uniti 3
KZ - Kazakistan 3
NO - Norvegia 3
PE - Perù 3
AM - Armenia 2
DO - Repubblica Dominicana 2
EU - Europa 2
GA - Gabon 2
GT - Guatemala 2
JM - Giamaica 2
KH - Cambogia 2
LK - Sri Lanka 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DM - Dominica 1
GE - Georgia 1
GH - Ghana 1
GS - Georgia del Sud e Isole Sandwich Australi 1
IS - Islanda 1
KG - Kirghizistan 1
Totale 28.011
Città #
Southend 2.044
Singapore 1.473
Fairfield 925
Ashburn 727
Jacksonville 700
San Jose 654
Chandler 600
Hong Kong 484
Woodbridge 483
Wilmington 478
Princeton 459
Santa Clara 451
Hefei 434
Ho Chi Minh City 428
Dong Ket 423
Seattle 419
Hanoi 400
Houston 369
Ann Arbor 340
Cambridge 315
Boardman 277
Dublin 256
Nanjing 226
Lauterbourg 223
Padova 214
Westminster 214
Council Bluffs 207
Beijing 202
Tokyo 189
Berlin 153
Los Angeles 135
Seoul 133
Medford 120
Saint Petersburg 119
Buffalo 116
Lomé 115
Mülheim 106
Bremen 105
Jinan 103
Shenyang 95
Mahé 92
Milan 79
Changsha 77
Nanchang 65
San Diego 65
Hebei 57
Bologna 56
Helsinki 55
Amman 54
Haiphong 51
Dallas 48
Des Moines 48
Zhengzhou 48
Abidjan 47
Bern 46
Da Nang 46
New York 45
Guangzhou 44
Sofia 44
Tianjin 44
Shanghai 42
Bengaluru 41
Jiaxing 39
Norwalk 38
Verona 38
Abeokuta 37
Hangzhou 36
Phoenix 35
Brussels 34
Olalla 32
Redondo Beach 32
Redwood City 32
Dearborn 29
Lanzhou 29
São Paulo 29
Yubileyny 29
San Francisco 28
Quận Bình Thạnh 27
Frankfurt am Main 26
Ningbo 26
Shenzhen 26
Vienna 26
Chicago 25
The Dalles 25
Biên Hòa 24
Hải Dương 24
Thái Nguyên 23
Taizhou 22
Wuhan 20
Can Tho 19
Falls Church 19
Rio de Janeiro 19
Taiyuan 19
Fuzhou 17
Istanbul 17
Kunming 17
Orem 16
Ha Long 15
Haikou 15
San Venanzo 15
Totale 18.087
Nome #
CHEMOKINES IN CARTILAGE DEGRADATION 352
Cell death in human articular chondrocyte: a morpho-functional study in micromass model 227
Polyamine delivery as a tool to modulate stem cell differentiation in skeletal tissue engineering 226
T cell suppression by osteoclasts in vitro 225
Hydroxytyrosol Prevents Increase of Osteoarthritis Markers in Human Chondrocytes Treated with Hydrogen Peroxide or Growth-Related Oncogene α 224
A molecular and histological characterization of cartilage from patients with Morquio syndrome. 222
Human osteoarthritic cartilage shows reduced in vivo expression of IL-4, a chondroprotective cytokine that differentially modulates IL-1β-stimulated production of chemokines and matrix-degrading enzymes in vitro 220
ECM remodelling plays a crucial role in the loss of maturational arrest of OA chondrocytes 213
Matrix metalloproteinase 13 loss associated with impaired extracellular matrix remodeling disrupts chondrocyte differentiation by concerted effects on multiple regulatory factors. 205
Vascular endothelial growth factor activities on osteoarthritic chondrocytes 200
A role for chemokines in the induction of chondrocyte phenotype modulation 199
IKKα/CHUK Regulates Extracellular Matrix Remodeling Independent of Its Kinase Activity to Facilitate Articular Chondrocyte Differentiation 194
Bone marrow concentrated cell transplantation: rationale for its use in the treatment of human osteochondral lesions 189
Altered expression of mismatch repair proteins associated with acquisition of microsatellite instability in a clonal model of human T lymphocyte aging. 188
Enhanced Osteoblastogenesis of Adipose-Derived Stem Cells on Spermine Delivery via β-Catenin Activation 186
3-HYDROXYTYROSOL PROTECTS CHONDROCYTES AGAINST MICRORNA-9 INCREASED BY OXIDATIVE STRESS 186
Microsatellite instability in “in vitro” ageing of T lymphocyte clones. 185
Soluble Receptor Activator of Nuclear Factor-kB Ligand (sRANKL)/Osteoprotegerin balance in ageing and age-associated diseases. 183
Quantitative immunodetection of key elements of polyphosphoinositide signal transduction in osteoblasts from arthritic patients shows a direct correlation with cell proliferation 182
Chondrocytes from patients with osteoarthritis express typical extracellular matrix molecules once grown onto a three-dimensional hyaluronan-based scaffold. 182
Osteoarthritis treated with mesenchymal stem cells on hyaluronan-based scaffold in rabbit. 180
CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients. 179
Human adipose stromal cells (ASC) for the regeneration of injured cartilage display genetic stability after in vitro culture expansion 178
Effect of two different preparations of platelet-rich plasma on synoviocytes 178
Cellular and molecular mechanisms in cartilage and bone repair. 175
Cellular and molecular events during chondrogenesis of human mesenchymal stromal cells grown in a three-dimensional hyaluronan based scaffold 175
IL-17, IL-1beta and TNF-alfa stimulate VEGF production by dedifferentiated chondrocytes 171
CXCL12 (SDF-1) and CXCL13 (BCA-1) chemokines significantly induce proliferation and collagen type I expression in osteoblasts from osteoarthritis patients. 171
Caratterizzazione molecolare delle strutture coinvolte nella rigenerazione del legamento crociato anteriore. 171
Mismatch repair system and aging: microsatellite instability in peripheral blood cells from differently aged participants. 170
Biological aspects of early osteoarthritis 170
POLYAMINES MAY FAVOR HYPERTROPHY AND TERMINAL DIFFERENTIATION OF OSTEOARTHRITIC CHONDROCYTES 169
CCL20 chemokine induces both osteoblast proliferation and osteoclast differentiation: increased levels of CCL20 are expressed in subchondral bone tissue of rheumatoid arthritis patients. 169
Chondrocyte hypertrophy and apoptosis induced by GROalpha require three-dimensional interaction with the extracellular matrix and a co-receptor role of chondroitin sulfate and are associated with the mitochondrial splicing variant of cathepsin B. 168
Clinical applications and biosafety of human adult mesenchymal stem cells 165
CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue or rheumatoid arthritis patients. 164
Ceramics and gene therapy. 164
Ligament repair: a molecular and immunohistological characterization 164
Cell and matrix morpho-functional analysis in chondrocyte micromasses. 163
High intensity laser therapy in the regeneration of human cartilage chronic lesions. 162
A role for apoptosis in the etiopathogenesis of osteochondritis dissecans of the ankle cartilage. 162
A system approach to tissue engineering processes and products. STEPS 160
Inhibition of CD95 apoptotic signaling by interferon-gamma in human chondrocytes is associated with increased expression of FLICE inhibitory protein 158
Increased serum vascular cell adhesion molecule (VCAM)-1 levels in patients with erosive hand osteoarthritis 158
ROLE OF POLYAMINES IN CHONDROGENESIS OF ADIPOSE DERIVED STEM CELLS 157
Systemic inflammation and antibodies to citrullinated peptides in hand osteoarthritis. 156
IL1-b and TNF-a differently modulate CXCL13 chemokine in stromal cells and osteoblasts isolated from osteoarthritis patients: evidence of changes associated to cell maturation. 155
Cathepsin B as a soluble marker to monitor the phenotypic stability of engineered cartilage. 155
Analysis of mesenchymal stem cells grown on a three-dimensional HYAFF-11-based prototype ligament scaffold. 155
Preparation method and growth factor content of platelet concentrate influence the osteogenic differentiation of bone marrow stromal cells 155
Traumatic extrusion of the talus-delayed re-implantation with autologous bone marrow mononuclear cell addition: A case report 154
In vivo expression of inflammatory cytokine receptors in the joint compartments of patients with arthritis. 154
Bone marrow derived cell characterization for the treament of early osteoarthritis lesions by a single step procedure. 154
Chondrogenesis of human mesenchymal stromal cells grown in a three-dimensional hyaluronan based scaffold. 153
CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients 152
Cathepsin B as a soluble marker to monitor the phenotypic stability of engineered cartilage. 151
Utilizzo di cellule staminali in ingegneria tissutale per la prevenzione di danni cartilaginei. € 78.020,00 151
Chondrogenesis of C3H10T1/2 murine stromal cells grown in a hyaluronic acid scaffold 151
CCL20 chemokine induce differential effects on proliferation and AKT signaling in human osteoblasts from osteoarthritis compared to rheumatoid arthritis patients 151
Analysis of ceramic devices with different porosities useful for osteochondral lesions repair. 150
Nuclear damages and oxidative stress: new perspectives for laminopathies 150
CCL20/CCR6 chemokine/receptor expression in bone tissue from osteoarthritis and rheumatoid arthritis patients: different response of osteoblasts in the two groups 150
Slug gene expression supports human osteoblast maturation. 149
Mechano-functional assessment of human mesenchymal stem cells grown in three-dimensional hyaluronan-based scaffolds for cartilage tissue engineering. 148
Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts. 148
Association of the interleukin-4/interleukin-4 receptor genetic variants with hand osteoathrtitis. 147
Comparison of alternative mesenchymal stem cell sources for cell banking and musculoskeletal advanced therapies. 147
Bone marrow "niche": evidences which support its use in vivo. 146
Simultaneous evaluation of circulating chemokine and cytokine profiles in elderly subjects by multiplex technology: relationship with zinc status. 143
Chondrocytes from osteoarthritis patients revert to their origin phenotype once grown onto a hyaluronan-based scaffold. 143
Cellular proliferation of osteoblasts from osteoarthritis patients is significantly increased by CXCL12 (SDF-1) and CXCL13 (BCA-1) chemokines. 143
L'ambiente articolare. 140
Expression of CXC chemokines and their receptors is modulated during chondrogenic differentiation of human mesenchymal stem cells grown in three-dimensional scaffold: evidence in native cartilage. 140
A functional link between ECM homeostasis and Sox-9 mediated control of beta-catenin activity. 140
Differential roles of IKKalpha and IKKbeta in chondrogenesis and OA inflammation revealed by retroviral mediated RNA interference. 139
Growth and phenotype analysis of mesenchymal stem cells grown in a hyaluronic acid configured ligament scaffold. 138
"RNA interference" mediata da vettori retrovirali per il knockdown della Metalloproteinase 13 in condrociti umani osteoartritici. 138
Histological and immunohistochemical analysis of an allogenic bone graft engineered with autologous bone marrow mononuclear cells in the treatment of a large segmental defect of the ulna. A case report. 138
Interleukin-4/Interleukin-4 receptor system activity in osteoarthritic chondrocytes. 138
Early-term effect of adult chondrocyte transplantation in an osteoarthritis animal model 138
The detached osteochondral fragment as a source of cells for autologous chondrocyte implantation (ACI). 137
Phenotype and growth analysis of mesenchimal stem cells cultured in a hyaluronic acid configured ligament scaffold. 136
A system approach to tissue engineering processes and products. STEPS 136
Ultrastructural analysis of human bone marrow mesenchymal stem cells during in vitro osteogenesis and chondrogenesis 135
Chondrogenic differentiation of murine and human mesenchymal stromal cells in hyaluronic acid scaffold: difference in gene expression and cell morphology. 134
Porous ceramics structured for bone-cartilage implants. 133
A multiple technical approach to human articular chondrocyte cell death. 133
Surface-dependent modulation of proliferation, bone matrix molecules, and inflammatory factors in human osteoblasts. 133
Differential requirements for IKKalpha and IKKbeta in the differentiation of primary human osteoarthritic chondrocytes 133
The detached osteochondral fragment as a source of cells for autologous chondrocyte implantation (ACI) in the ankle joint. 132
Polyamine depletion inhibits apoptosis following blocking of survival pathways in human chondrocytes stimulated by tumor necrosis factor-alpha. 132
SREBP1 interaction with prelamin A forms: a pathogenic mechanism for lipodystrophic laminopathies. 132
Role of Slug transcription factor in human mesenchymal stem cells 131
Extracellular calcium chronically induced human osteoblasts effects: specific modulation of osteocalcin and collagen type XV 131
Chemokines in cartilage degradation in osteoarthritis. 130
Engineered mesenchymal stem cells combined with gene therapy for osteoarticular diseases. STEMGENOS € 196.214,00 129
Microsatellite instability and compromised mismatch repair gene expression during in vitro passaging of monoclonal human T lymphocytes. 129
Human chondrocytes and mesenchymal stem cells grown onto engineered scaffold. 129
Molecular characterization of human cartilage biopsies following autologous chondrocyte transplantation. 129
Interleukin-4/interleukin-4 receptor gene polymorphisms in hand osteoarthritis 129
Totale 16.192
Categoria #
all - tutte 73.232
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.232


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021863 0 0 0 0 0 0 0 0 0 0 0 863
2021/20223.283 273 153 230 312 295 242 55 249 97 129 562 686
2022/20233.289 361 501 179 506 248 228 100 160 518 89 262 137
2023/2024656 50 154 54 57 55 83 46 35 24 49 21 28
2024/20253.068 59 717 319 285 623 156 170 41 9 52 45 592
2025/20267.856 641 859 914 664 825 480 538 552 1.391 397 294 301
Totale 28.325